Literature DB >> 26855814

Diagnosis and management of functional symptoms in inflammatory bowel disease in remission.

Carlos Teruel1, Elena Garrido1, Francisco Mesonero1.   

Abstract

Inflammatory bowel disease (IBD) patients in remission may suffer from gastrointestinal symptoms that resemble irritable bowel syndrome (IBS). Knowledge on this issue has increased considerably in the last decade, and it is our intention to review and summarize it in the present work. We describe a problematic that comprises physiopathological uncertainties, diagnostic difficulties, as IBS-like symptoms are very similar to those produced by an inflammatory flare, and the necessity of appropriate management of these patients, who, although in remission, have impaired quality of life. Ultimately, from almost a philosophical point of view, the presence of IBS-like symptoms in IBD patients in remission supposes a challenge to the traditional functional-organic dichotomy, suggesting the need for a change of paradigm.

Entities:  

Keywords:  Crohn’s disease; Functional gastrointestinal disease; Inflammatory bowel disease; Irritable bowel syndrome; Ulcerative colitis

Year:  2016        PMID: 26855814      PMCID: PMC4734957          DOI: 10.4292/wjgpt.v7.i1.78

Source DB:  PubMed          Journal:  World J Gastrointest Pharmacol Ther        ISSN: 2150-5349


  114 in total

Review 1.  AGA technical review on irritable bowel syndrome.

Authors:  Douglas A Drossman; Michael Camilleri; Emeran A Mayer; William E Whitehead
Journal:  Gastroenterology       Date:  2002-12       Impact factor: 22.682

2.  Early clinical remission and normalisation of CRP are the strongest predictors of efficacy, mucosal healing and dose escalation during the first year of adalimumab therapy in Crohn's disease.

Authors:  L S Kiss; T Szamosi; T Molnar; P Miheller; L Lakatos; A Vincze; K Palatka; Z Barta; B Gasztonyi; A Salamon; G Horvath; G T Tóth; K Farkas; J Banai; Z Tulassay; F Nagy; M Szenes; G Veres; B D Lovasz; Z Vegh; P A Golovics; M Szathmari; M Papp; P L Lakatos
Journal:  Aliment Pharmacol Ther       Date:  2011-08-24       Impact factor: 8.171

3.  Tricyclic antidepressants for management of residual symptoms in inflammatory bowel disease.

Authors:  Heba N Iskandar; Benjamin Cassell; Navya Kanuri; C Prakash Gyawali; Alexandra Gutierrez; Themistocles Dassopoulos; Matthew A Ciorba; Gregory S Sayuk
Journal:  J Clin Gastroenterol       Date:  2014 May-Jun       Impact factor: 3.062

4.  Abnormal intestinal permeability predicts relapse in inactive Crohn disease.

Authors:  I D Arnott; K Kingstone; S Ghosh
Journal:  Scand J Gastroenterol       Date:  2000-11       Impact factor: 2.423

5.  Managing symptoms of irritable bowel syndrome in patients with inflammatory bowel disease.

Authors:  Michael Camilleri
Journal:  Gut       Date:  2011-02-02       Impact factor: 23.059

6.  Health-related quality of life in Swedish patients with ulcerative colitis.

Authors:  H Hjortswang; M Ström; S Almer
Journal:  Am J Gastroenterol       Date:  1998-11       Impact factor: 10.864

Review 7.  Refractory inflammatory bowel disease-could it be an irritable bowel?

Authors:  Jie Meng; Anurag Agrawal; Peter J Whorwell
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2012-09-11       Impact factor: 46.802

8.  Grading Crohn disease activity with MRI: interobserver variability of MRI features, MRI scoring of severity, and correlation with Crohn disease endoscopic index of severity.

Authors:  Jeroen A W Tielbeek; Jesica C Makanyanga; Shandra Bipat; Doug A Pendsé; C Yung Nio; Frans M Vos; Stuart A Taylor; Jaap Stoker
Journal:  AJR Am J Roentgenol       Date:  2013-12       Impact factor: 3.959

9.  Alterations in composition and diversity of the intestinal microbiota in patients with diarrhea-predominant irritable bowel syndrome.

Authors:  I M Carroll; T Ringel-Kulka; J P Siddle; Y Ringel
Journal:  Neurogastroenterol Motil       Date:  2012-02-20       Impact factor: 3.598

Review 10.  Measuring disease activity in Crohn's disease: what is currently available to the clinician.

Authors:  Renata D'Incà; Roberta Caccaro
Journal:  Clin Exp Gastroenterol       Date:  2014-05-20
View more
  11 in total

1.  Irritable Bowel Syndrome on Inflammatory Bowel Disease in Deep Remission: No Relation with Remission Deepening and Inflammation.

Authors:  Orhan Sezgin; Burcu Boztepe; Enver Üçbilek; Engin Altintas; Havva Didem Celikcan
Journal:  Turk J Gastroenterol       Date:  2021-10       Impact factor: 1.852

Review 2.  Managing Pain and Psychosocial Care in IBD: a Primer for the Practicing Gastroenterologist.

Authors:  Emily Weaver; Eva Szigethy
Journal:  Curr Gastroenterol Rep       Date:  2020-03-17

3.  Granulocyte-colony-stimulating factor (G-CSF) signaling in spinal microglia drives visceral sensitization following colitis.

Authors:  Lilian Basso; Tamia K Lapointe; Mircea Iftinca; Candace Marsters; Morley D Hollenberg; Deborah M Kurrasch; Christophe Altier
Journal:  Proc Natl Acad Sci U S A       Date:  2017-10-02       Impact factor: 11.205

Review 4.  Eosinophilic esophagitis: What can we learn from Crohn's disease?

Authors:  Javier Molina-Infante; Alain M Schoepfer; Alfredo J Lucendo; Evan S Dellon
Journal:  United European Gastroenterol J       Date:  2016-09-29       Impact factor: 4.623

5.  Symptoms compatible with functional bowel disorders are common in patients with quiescent ulcerative colitis and influence the quality of life but not the course of the disease.

Authors:  Georgios Mavroudis; Magnus Simren; Börje Jonefjäll; Lena Öhman; Hans Strid
Journal:  Therap Adv Gastroenterol       Date:  2019-02-19       Impact factor: 4.409

Review 6.  Gastrointestinal motility and absorptive disorders in patients with inflammatory bowel diseases: Prevalence, diagnosis and treatment.

Authors:  Luísa Leite Barros; Alberto Queiroz Farias; Ali Rezaie
Journal:  World J Gastroenterol       Date:  2019-08-21       Impact factor: 5.742

7.  Association between Dietary Isoflavone Intake and Ulcerative Colitis Symptoms in Polish Caucasian Individuals.

Authors:  Dominika Skolmowska; Dominika Głąbska; Dominika Guzek; Gustaw Lech
Journal:  Nutrients       Date:  2019-08-17       Impact factor: 5.717

8.  Intake of dairy protein during pregnancy in IBD and risk of SGA in a Norwegian population-based mother and child cohort.

Authors:  May-Bente Bengtson; Margaretha Haugen; Anne Lise Brantsæter; Geir Aamodt; Morten H Vatn
Journal:  BMC Gastroenterol       Date:  2020-02-03       Impact factor: 3.067

Review 9.  Animal Models for Functional Gastrointestinal Disorders.

Authors:  Alison Accarie; Tim Vanuytsel
Journal:  Front Psychiatry       Date:  2020-11-11       Impact factor: 4.157

10.  Association between antidepressant medication use and steroid dependency in patients with ulcerative colitis: a population-based study.

Authors:  Jonathan Blackwell; Christopher Alexakis; Sonia Saxena; Hanna Creese; Alex Bottle; Irene Petersen; Matthew Hotopf; Richard C G Pollok
Journal:  BMJ Open Gastroenterol       Date:  2021-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.